Hale, Zachary D.
Kong, Xiowen
Haymart, Brian
Gu, Xiaokui
Kline-Rogers, Eva
Almany, Steve
Kozlowski, Jay
Krol, Gregory D.
Kaatz, Scott
Froehlich, James B.
Barnes, Geoffrey D.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (2-T32-HL007853-16)
Article History
First Online: 11 November 2016
Compliance with ethical standards
:
: ZH, XK, BH, XG, JK, GK—none; EKR—consultant: Janssen, ACP, board member: AC Forum; SA—consulting fees/honoraria: Kona, Trice Orthopedics, Micardia; ownership/partnership/principal: Biostar Ventures, Ablative Solutions, research/research grants: Boston Scientific Watchman, Abbott Absorb trial; SK—consultant: BI, Janssen Dalichi Sankyo, Bristol Myer Squibb, Pfizer, speaker’s bureau: Janssen, Boehringer-Ingelheim, Bristol Myer Squibb, Pfizer, CSL Behring; JF—consultant Merck, Bristol Myer Squibb, Pfizer, Sanofi-Aventis, Janssen Pharmaceuticals; research grants: Fibromuscular Disease Society of America, Blue Cross/Blue Shield of Michigan; GB—consulting for Portola and Aralez, research grants from Blue Cross/Blue Shield of Michigan and BMS/Pfizer.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.